Champions Oncology, Inc.CSBRNASDAQ
Loading
Year-over-year net income growth rate
Percentile
P10
Near historical low
vs 5Y Ago
0x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q1 2026 | -193.31% |
| Q4 2025 | 168.58% |
| Q3 2025 | 76.23% |
| Q2 2025 | -140.80% |
| Q1 2025 | 517.45% |
| Q4 2024 | -44.55% |
| Q3 2024 | 1304.59% |
| Q2 2024 | 95.69% |
| Q1 2024 | -22.16% |
| Q4 2023 | 19.29% |
| Q3 2023 | -0.20% |
| Q2 2023 | -5.00% |
| Q1 2023 | -15143.75% |
| Q4 2022 | 94.98% |
| Q3 2022 | 7.27% |
| Q2 2022 | -143.71% |
| Q1 2022 | 184.12% |
| Q4 2021 | 261.05% |
| Q3 2021 | 64.24% |
| Q2 2021 | -165.00% |
| Q1 2021 | 73900.00% |
| Q4 2020 | -98.67% |
| Q3 2020 | 103.54% |
| Q2 2020 | -619.90% |
| Q1 2020 | 32.57% |
| Q4 2019 | 147.89% |
| Q3 2019 | -154.37% |
| Q2 2019 | 31.71% |
| Q1 2019 | -238.20% |
| Q4 2018 | -44.61% |
| Q3 2018 | 176.27% |
| Q2 2018 | -731.58% |
| Q1 2018 | 19.15% |
| Q4 2017 | 86.05% |
| Q3 2017 | 72.19% |
| Q2 2017 | -72.04% |
| Q1 2017 | -179.56% |
| Q4 2016 | 80.20% |
| Q3 2016 | 1.09% |
| Q2 2016 | -6.72% |